The U.S. Supreme Court has barred patients from receiving medication in the mail to have a nonsurgical abortion early in their pregnancy. The court reinstated a federal requirement that patients must visit a doctor’s office or health center to obtain mifepristone — also known as RU-486 — overturning a lower court ruling that the drug could be mailed to reduce unnecessary travel during the pandemic. The decision will force some to drive over 1,000 miles to get the pill. The three liberal judges on the court dissented. Sonia Sotamaor said the ruling “imposes an unnecessary, irrational and unjustifiable undue burden on women seeking to exercise their right to choose.”